rs763719276

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_005670.4(EPM2A):​c.157G>A​(p.Ala53Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000888 in 1,362,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A53G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000087 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000089 ( 0 hom. )

Consequence

EPM2A
NM_005670.4 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 2.63

Publications

2 publications found
Variant links:
Genes affected
EPM2A (HGNC:3413): (EPM2A glucan phosphatase, laforin) This gene encodes a dual-specificity phosphatase and may be involved in the regulation of glycogen metabolism. The protein acts on complex carbohydrates to prevent glycogen hyperphosphorylation, thus avoiding the formation of insoluble aggregates. Loss-of-function mutations in this gene have been associated with Lafora disease, a rare, adult-onset recessive neurodegenerative disease, which results in myoclonus epilepsy and usually results in death several years after the onset of symptoms. The disease is characterized by the accumulation of insoluble particles called Lafora bodies, which are derived from glycogen. [provided by RefSeq, Jan 2018]
EPM2A-DT (HGNC:48990): (EPM2A divergent transcript)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005670.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.034620583).
BP6
Variant 6-145735342-C-T is Benign according to our data. Variant chr6-145735342-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 205430.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000891 (108/1212682) while in subpopulation MID AF = 0.002 (7/3496). AF 95% confidence interval is 0.000939. There are 0 homozygotes in GnomAdExome4. There are 55 alleles in the male GnomAdExome4 subpopulation. Median coverage is 35. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005670.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPM2A
NM_005670.4
MANE Select
c.157G>Ap.Ala53Thr
missense
Exon 1 of 4NP_005661.1O95278-1
EPM2A
NM_001018041.2
c.157G>Ap.Ala53Thr
missense
Exon 1 of 5NP_001018051.1O95278-2
EPM2A
NM_001368130.1
c.157G>Ap.Ala53Thr
missense
Exon 1 of 3NP_001355059.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPM2A
ENST00000367519.9
TSL:1 MANE Select
c.157G>Ap.Ala53Thr
missense
Exon 1 of 4ENSP00000356489.3O95278-1
EPM2A
ENST00000435470.2
TSL:1
c.157G>Ap.Ala53Thr
missense
Exon 1 of 5ENSP00000405913.2O95278-2
EPM2A
ENST00000638262.1
TSL:1
c.157G>Ap.Ala53Thr
missense
Exon 1 of 3ENSP00000492876.1O95278-5

Frequencies

GnomAD3 genomes
AF:
0.0000866
AC:
13
AN:
150056
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000663
Gnomad ASJ
AF:
0.00146
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000104
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000214
AC:
15
AN:
69968
AF XY:
0.000171
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000163
Gnomad ASJ exome
AF:
0.00114
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000116
Gnomad OTH exome
AF:
0.000507
GnomAD4 exome
AF:
0.0000891
AC:
108
AN:
1212682
Hom.:
0
Cov.:
35
AF XY:
0.0000923
AC XY:
55
AN XY:
595930
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24520
American (AMR)
AF:
0.000186
AC:
4
AN:
21488
Ashkenazi Jewish (ASJ)
AF:
0.000827
AC:
16
AN:
19336
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24044
South Asian (SAS)
AF:
0.000155
AC:
9
AN:
58078
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29468
Middle Eastern (MID)
AF:
0.00200
AC:
7
AN:
3496
European-Non Finnish (NFE)
AF:
0.0000599
AC:
59
AN:
984296
Other (OTH)
AF:
0.000271
AC:
13
AN:
47956
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000866
AC:
13
AN:
150056
Hom.:
0
Cov.:
33
AF XY:
0.0000546
AC XY:
4
AN XY:
73204
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41222
American (AMR)
AF:
0.0000663
AC:
1
AN:
15084
Ashkenazi Jewish (ASJ)
AF:
0.00146
AC:
5
AN:
3436
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5122
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9810
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000104
AC:
7
AN:
67264
Other (OTH)
AF:
0.00
AC:
0
AN:
2060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.448
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.0000982

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
not provided (2)
-
-
1
Inborn genetic diseases (1)
-
1
-
Progressive myoclonic epilepsy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
16
DANN
Benign
0.93
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.64
T
M_CAP
Pathogenic
0.48
D
MetaRNN
Benign
0.035
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.3
L
PhyloP100
2.6
PrimateAI
Pathogenic
0.80
D
PROVEAN
Benign
0.33
N
REVEL
Benign
0.14
Sift
Benign
0.60
T
Sift4G
Benign
0.15
T
PromoterAI
-0.069
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
gMVP
0.26
Mutation Taster
=71/29
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs763719276;
hg19: chr6-146056478;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.